Genflow Biosciences plc (LON:GENF)
London
· Delayed Price · Currency is GBP · Price in GBX 2.800
+0.300 (12.00%)
Apr 28, 2026, 4:35 PM GMT
Genflow Biosciences Market Cap
Genflow Biosciences has a market cap or net worth of 13.39 million as of April 28, 2026. Its market cap has increased by 226.14% in one year.
Market Cap
13.39M
Enterprise Value
13.11M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.80
Market Cap Chart
Since January 17, 2022, Genflow Biosciences's market cap has decreased from 33.64M to 13.39M, a decrease of -60.19%. That is a compound annual growth rate of -19.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 13.39M | 46.66% |
| Dec 31, 2025 | 9.13M | 51.36% |
| Dec 31, 2024 | 6.03M | 44.72% |
| Dec 29, 2023 | 4.17M | -40.63% |
| Dec 30, 2022 | 7.02M | -79.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IXICO | 15.26M |
| Fusion Antibodies | 18.13M |
| Oxford BioDynamics | 9.87M |
| Aptamer Group | 20.73M |
| Futura Medical | 8.43M |
| Cizzle Biotechnology Holdings | 8.32M |
| Arecor Therapeutics | 24.92M |
| SkinBioTherapeutics | 25.27M |